Effects and safety of rituximab in systemic sclerosis: an analysis from the European Scleroderma Trial and Research (EUSTAR) groupSuzana Jordan, Thierry Zénone, Jacob M. van Laar et al.|Annals of the Rheumatic Diseases|2014Cited by 432
Does the Impact of <scp>COVID</scp>‐19 on Patients With Systemic Sclerosis Change Over Time?Elisabeth Deibel, Fabian A. Mendoza, Patrícia Carreira et al.|Arthritis Care & Research|2023Cited by 2